Results 181 to 190 of about 26,318 (262)

PAX8‐positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles – A clinicopathologic study of 101 consecutive cases with next‐generation sequencing in 20 cases

open access: yesHistopathology, Volume 88, Issue 7, Page 1315-1323, June 2026.
PAX8 expression in urothelial carcinoma was investigated in 101 consecutive transurethral resections of the urinary bladder. PAX8 was positive in 10% of cases, with targeted molecular testing of these cases revealing universal TERT promoter mutations and frequent alterations in TSC1, NOTCH1 and WT1. Aims PAX8 immunohistochemistry (IHC) is often used to
Sarah Mae Lammert   +5 more
wiley   +1 more source

Vaginal Microbiota and Ovarian Cancer: A New Frontier in Immunomodulation and Diagnosis

open access: yesImmunology, Volume 178, Issue 2, Page 209-217, June 2026.
Microbial imbalance, dysbiosis, plays a role in ovarian carcinogenesis by interacting with the immune system and altering inflammatory pathways, notably Th17 pathways. In contrast, eubiosis, characterised by Lactobacillus dominance, protects against infections and maintains hormone metabolism.
Wafa Babay   +4 more
wiley   +1 more source

The karyometric signature is altered in fallopian tubes with serous tubal intraepithelial carcinoma. [PDF]

open access: yesGynecol Oncol
Rodriguez GC   +7 more
europepmc   +1 more source

Towards endoscopic optical imaging of the fallopian tubes for tubo-ovarian cancer detection

open access: yes
Tubo-ovarian cancers are the most lethal gynecologic cancer. Early diagnosis is associated with better patient outcomes, but there are currently no effective screening measures.
Malone, Jeanie Hakansson
core  

Assessing the impact of deep-learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes. [PDF]

open access: yesJ Pathol Clin Res
Bogaerts JM   +33 more
europepmc   +1 more source

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels. [PDF]

open access: yesInt J Cancer, 2021
Crosbie EJ   +12 more
europepmc   +1 more source

Multimodal Optical Imaging of Ex Vivo Fallopian Tubes to Distinguish Early and Occult Tubo-Ovarian Cancers. [PDF]

open access: yesCancers (Basel)
Malone J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy